211 related articles for article (PubMed ID: 28827399)
1. Identification of Nidogen 1 as a lung metastasis protein through secretome analysis.
Alečković M; Wei Y; LeRoy G; Sidoli S; Liu DD; Garcia BA; Kang Y
Genes Dev; 2017 Jul; 31(14):1439-1455. PubMed ID: 28827399
[TBL] [Abstract][Full Text] [Related]
2. Increased NID1 Expression among Breast Cancer Lung Metastatic Women; A Comparative Analysis between Naive and Treated Cases.
Urooj T; Wasim B; Mushtaq S; Haider G; Shah SNN; Ghani R; Qureshi MFH
Recent Pat Anticancer Drug Discov; 2020; 15(1):59-69. PubMed ID: 32116201
[TBL] [Abstract][Full Text] [Related]
3. The cancer secretome, current status and opportunities in the lung, breast and colorectal cancer context.
Schaaij-Visser TB; de Wit M; Lam SW; Jiménez CR
Biochim Biophys Acta; 2013 Nov; 1834(11):2242-58. PubMed ID: 23376433
[TBL] [Abstract][Full Text] [Related]
4. Secretome proteomics for discovery of cancer biomarkers.
Makridakis M; Vlahou A
J Proteomics; 2010 Nov; 73(12):2291-305. PubMed ID: 20637910
[TBL] [Abstract][Full Text] [Related]
5. Quantitative Secretomic Analysis Identifies Extracellular Protein Factors That Modulate the Metastatic Phenotype of Non-Small Cell Lung Cancer.
Hu R; Huffman KE; Chu M; Zhang Y; Minna JD; Yu Y
J Proteome Res; 2016 Feb; 15(2):477-86. PubMed ID: 26736068
[TBL] [Abstract][Full Text] [Related]
6. Quantitative secretome analysis reveals that COL6A1 is a metastasis-associated protein using stacking gel-aided purification combined with iTRAQ labeling.
Chiu KH; Chang YH; Wu YS; Lee SH; Liao PC
J Proteome Res; 2011 Mar; 10(3):1110-25. PubMed ID: 21186846
[TBL] [Abstract][Full Text] [Related]
7. Absence of the basement membrane component nidogen 2, but not of nidogen 1, results in increased lung metastasis in mice.
Mokkapati S; Bechtel M; Reibetanz M; Miosge N; Nischt R
J Histochem Cytochem; 2012 Apr; 60(4):280-9. PubMed ID: 22260998
[TBL] [Abstract][Full Text] [Related]
8. miR-629-3p may serve as a novel biomarker and potential therapeutic target for lung metastases of triple-negative breast cancer.
Wang J; Song C; Tang H; Zhang C; Tang J; Li X; Chen B; Xie X
Breast Cancer Res; 2017 Jun; 19(1):72. PubMed ID: 28629464
[TBL] [Abstract][Full Text] [Related]
9. BST-2 is a potential activator of invasion and migration in tamoxifen-resistant breast cancer cells.
Yi EH; Yoo H; Noh KH; Han S; Lee H; Lee JK; Won C; Kim BH; Kim MH; Cho CH; Ye SK
Biochem Biophys Res Commun; 2013 Jun; 435(4):685-90. PubMed ID: 23702480
[TBL] [Abstract][Full Text] [Related]
10. Entering a new era of rational biomarker discovery for early detection of melanoma metastases: secretome analysis of associated stroma cells.
Paulitschke V; Kunstfeld R; Mohr T; Slany A; Micksche M; Drach J; Zielinski C; Pehamberger H; Gerner C
J Proteome Res; 2009 May; 8(5):2501-10. PubMed ID: 19222175
[TBL] [Abstract][Full Text] [Related]
11. Role of the focal adhesion protein kindlin-1 in breast cancer growth and lung metastasis.
Sin S; Bonin F; Petit V; Meseure D; Lallemand F; Bièche I; Bellahcène A; Castronovo V; de Wever O; Gespach C; Lidereau R; Driouch K
J Natl Cancer Inst; 2011 Sep; 103(17):1323-37. PubMed ID: 21832234
[TBL] [Abstract][Full Text] [Related]
12. Identification of annexin II as a novel secretory biomarker for breast cancer.
Jeon YR; Kim SY; Lee EJ; Kim YN; Noh DY; Park SY; Moon A
Proteomics; 2013 Nov; 13(21):3145-56. PubMed ID: 24019232
[TBL] [Abstract][Full Text] [Related]
13. Tumour stroma-derived lipocalin-2 promotes breast cancer metastasis.
Ören B; Urosevic J; Mertens C; Mora J; Guiu M; Gomis RR; Weigert A; Schmid T; Grein S; Brüne B; Jung M
J Pathol; 2016 Jul; 239(3):274-85. PubMed ID: 27038000
[TBL] [Abstract][Full Text] [Related]
14. RBM5/H37 tumor suppressor, located at the lung cancer hot spot 3p21.3, alters expression of genes involved in metastasis.
Oh JJ; Taschereau EO; Koegel AK; Ginther CL; Rotow JK; Isfahani KZ; Slamon DJ
Lung Cancer; 2010 Dec; 70(3):253-62. PubMed ID: 20338664
[TBL] [Abstract][Full Text] [Related]
15. LincIN, a novel NF90-binding long non-coding RNA, is overexpressed in advanced breast tumors and involved in metastasis.
Jiang Z; Slater CM; Zhou Y; Devarajan K; Ruth KJ; Li Y; Cai KQ; Daly M; Chen X
Breast Cancer Res; 2017 May; 19(1):62. PubMed ID: 28558830
[TBL] [Abstract][Full Text] [Related]
16. Signatures of protein expression revealed by secretome analyses of cancer associated fibroblasts and melanoma cell lines.
Liberato T; Pessotti DS; Fukushima I; Kitano ES; Serrano SMT; Zelanis A
J Proteomics; 2018 Mar; 174():1-8. PubMed ID: 29275043
[TBL] [Abstract][Full Text] [Related]
17. Mast cells impair melanoma cell homing and metastasis by inhibiting HMGA1 secretion.
Benito-Martin A; Nogués L; Hergueta-Redondo M; Castellano-Sanz E; Garvin E; Cioffi M; Sola-Castrillo P; Buehring W; Ximénez-Embún P; Muñoz J; Matei I; Villanueva J; Peinado H
Immunology; 2023 Feb; 168(2):362-373. PubMed ID: 36352838
[TBL] [Abstract][Full Text] [Related]
18. The Gαh-PLCδ1 signaling axis drives metastatic progression in triple-negative breast cancer.
Huang SP; Liu PY; Kuo CJ; Chen CL; Lee WJ; Tsai YH; Lin YF
J Hematol Oncol; 2017 Jun; 10(1):114. PubMed ID: 28576130
[TBL] [Abstract][Full Text] [Related]
19. In-depth proteomic profiling of the uveal melanoma secretome.
Angi M; Kalirai H; Prendergast S; Simpson D; Hammond DE; Madigan MC; Beynon RJ; Coupland SE
Oncotarget; 2016 Aug; 7(31):49623-49635. PubMed ID: 27391064
[TBL] [Abstract][Full Text] [Related]
20. SRT1720, a SIRT1 activator, promotes tumor cell migration, and lung metastasis of breast cancer in mice.
Suzuki K; Hayashi R; Ichikawa T; Imanishi S; Yamada T; Inomata M; Miwa T; Matsui S; Usui I; Urakaze M; Matsuya Y; Ogawa H; Sakurai H; Saiki I; Tobe K
Oncol Rep; 2012 Jun; 27(6):1726-32. PubMed ID: 22470132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
